Year-end Sale % OFF 
Abstract
Dementia including Alzheimer’s disease, is a severe neurodegenerative disorder characterized by progressive cognitive deficits as major symptom. The compositions (BBGS171) including extracts from root of Wongam (a Glycyrriza cultivar), seed of Sorghum bicolor (L.) pupae of Moench and Bombyx mori L. was selected based on preliminary experiments on the ability to improve cognition function in vitro. BBGS171 showed inhibitory activity on cholinesterases, such as acetylcholinesterase (AChE) and butyrylcholinesterase (BuchE) and inhibited nitric oxide (NO) production in lipopolysaccharide (LPS)-treated BV2 cells (a microglial cell line). The Y-maze test and passive avoidance test (PAT) were used to evaluate the behavior of an animal model of scopolamine-induced cognitive impairment. Rats administered BBGS171 (EM, extract mixture) in the diet showed better spontaneous alteration and escape latency than those of control rats. Levels of hippocampal choline acetyltransferase (ChAT) and serum acetylcholine (ACh) were significantly higher in the BBGS171 diet group than in the control group. Expression levels of brain-derived neurotrophic factor (BDNF) and extracellular signal-regulated kinase (ERK) 1/2 in the hippocampus of the BBGS171 diet group were also higher than those of control group. These results suggest that BBGS171 (EM) could ameliorate cognition impairment and showed potential as a useful functional material.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
